✦ LIBER ✦

Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer

✍ Scribed by Amita Patnaik, Kyriakos P. Papadopoulos…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, pharmacokinetics, and activity o

✍ Razelle Kurzrock; Sanjay Goel; Jennifer Wheler; David Hong; Siqing Fu; Keyvan Re 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

423 POSTER Phase I dose escalation study

✍ D. Toshihiko; N. Fuse; A. Ohtsu; Y. Matsumura; T. Hamaguchi; K. Kato; Y. Shimada 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

427 POSTER Pharmacokinetics (PK) of EZN-

✍ A. Patnaik; M. Goldston; C. Takimoto; A. Tolcher; K. Papadopoulos; T. Bekaii-Saa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 87 KB

398 POSTER Phase I, pharmacokinetic (PK)

✍ N. Lewis; R.B. Cohen; Y. Nishida; H.I. Hurwitz; C. Arrowwood; H.E. Uronis; F. Ga 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

704 POSTER A phase I dose escalation and

✍ E. Raymond; F. Goldwasser; G. Bousquet; C. Le Tourneau; S. Faivre; H. de-Montser 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB